Literature DB >> 25450815

Association between insulin resistance and risk of complications in children and adolescents with type 1 diabetes.

Andrea G Krochik1, Marianela Botto2, Mónica Bravo3, Mirta Hepner4, Juan P Frontroth4, Miguel Miranda5, Carmen Mazza2.   

Abstract

BACKGROUND: It has been hypothesized that insulin resistance may be involved in the development of type 1 diabetes complications and early diagnosis would be important for their prevention. Our aim was to study insulin resistance in our population of children with type 1 diabetes and to identify associated early risk factors for micro- and macrovascular complications.
METHODS: A descriptive, cross-sectional study was conducted including 150 children with type 1 diabetes. Anthropometric, bioelectric impedance, carotid Doppler ultrasonography, electromyography, and conduction velocity studies were performed. Baseline plasma glucose, lipid profile, uric acid, plasma thyrotropin, glycosylated hemoglobin A1C, and microalbuminuria were assessed. More insulin-resistant patients were defined as those having an estimated glucose disposal rate (eGDR) value below the first quartile.
RESULTS: Clinically manifest microvascular complications were not found in any of the patients. More insulin-resistant patients had a greater sub scapular fold thickness, a higher incidence of obesity (12% vs. 1.7% p 0.007), higher fructosamine levels (496 vs. 403 p<0.00019, and a higher incidence of altered lipid metabolism (70% vs. 39% p 0.0007).
CONCLUSION: In the subgroup of patients with lower eGDR there were more children with lipid disorders, obesity, and worse diabetic control, which, if not corrected, may lead to development of micro- and macrovascular complications.
Copyright © 2014 Diabetes India. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Children; Complications; Insulin resistance; Type 1 diabetes

Mesh:

Substances:

Year:  2014        PMID: 25450815     DOI: 10.1016/j.dsx.2014.09.013

Source DB:  PubMed          Journal:  Diabetes Metab Syndr        ISSN: 1871-4021


  6 in total

1.  Overweight adolescents with type 2 diabetes have significantly higher lipoprotein abnormalities than those with type 1 diabetes.

Authors:  Lynae J Hanks; James Heath Pelham; Shalini Vaid; Krista Casazza; Ambika P Ashraf
Journal:  Diabetes Res Clin Pract       Date:  2016-03-07       Impact factor: 5.602

2.  Overweight and obese children with optimal control in the T1D Exchange Registry: How are they different from lean children with optimal control?

Authors:  Myrto Eleni Flokas; Alexander Zeymo; Mihriye Mete; Henry Anhalt; Kristina I Rother; Evgenia Gourgari
Journal:  J Diabetes Complications       Date:  2019-12-30       Impact factor: 2.852

Review 3.  Glucose-Lowering Therapy beyond Insulin in Type 1 Diabetes: A Narrative Review on Existing Evidence from Randomized Controlled Trials and Clinical Perspective.

Authors:  Felix Aberer; Thomas R Pieber; Max L Eckstein; Harald Sourij; Othmar Moser
Journal:  Pharmaceutics       Date:  2022-05-31       Impact factor: 6.525

4.  Glycemic control and variability in association with body mass index and body composition over 18months in youth with type 1 diabetes.

Authors:  Leah M Lipsky; Benjamin Gee; Aiyi Liu; Tonja R Nansel
Journal:  Diabetes Res Clin Pract       Date:  2016-08-06       Impact factor: 5.602

5.  Prevalence of Obesity and Metabolic Syndrome in Children with Type 1 Diabetes: A Comparative Assessment Based on Criteria Established by the International Diabetes Federation, World Health Organisation and National Cholesterol Education Program

Authors:  Özlem Yayıcı Köken; Cengiz Kara; Gülay Can Yılmaz; Hasan Murat Aydın
Journal:  J Clin Res Pediatr Endocrinol       Date:  2019-08-22

6.  The effects of metformin in type 1 diabetes mellitus.

Authors:  Selvihan Beysel; Ilknur Ozturk Unsal; Muhammed Kizilgul; Mustafa Caliskan; Bekir Ucan; Erman Cakal
Journal:  BMC Endocr Disord       Date:  2018-01-16       Impact factor: 2.763

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.